The group's principal activities are to develop, manufacture and market insulin delivery, minimally-invasive fluid sampling procedures and cancer detection products. The insulin delivery and glucose monitoring activities are marketed under brand name simplechoice, which includes insulin pump disposables and a non-invasive interstitial fluid based continuous glucose monitoring development program. The group has collaborative agreements with medical device companies in helping, developing, commercialising and selling these products.
